Millennium Pharmaceuticals has outbid Genzyme Corp. to acquire AnorMed, offering $515 million for the biotech firm.
RxBlog
RxBlog is a simple weblog dedicatd to pharmaceutical news and drug information.- RxBlog (tm) com/net
Is a Trademark - Rx Drugs Specific Search
Sponsor Media
Sponsor: 16x20.com
Great Wall Art For Everyone
RxBlog Resources
- Subscribe to RSS
- BlogPad
Network of Blogs - Start Simple
Publishers
RxBlog Blogroll
- Pfizer
Our purpose is helping people live longer, healthier, happier lives. Our route to that purpose is through discovering and developing breakthrough medicines; providing information on prevention, wellness, and treatment. - Schering-Plough
We aspire to earn the trust of doctors, patients and customers by providing a steady flow of innovative, science-based medicines and services that improve the health and well-being of people around the world. - Wyeth
Wyeth pharmaceutical company brings health care products, medicines and vaccines that aim to improve lives and deliver value to customers. - Novartis
Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance the quality of life. - GlaxoSmithKline
Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. - AstraZeneca
One of the world's leading pharmaceutical companies providing effective prescription drugs and innovative prescription medicines in many important therapeutic areas. - Merck
A global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs.
My Online Status
Recent Comments
Healthcare
Sponsor Video
Sponsor: 16x20.com
Great Wall Art For Everyone
« Savient Files Patent Infringement Suit Against Barr Labs | Main | European Court of First Instance (CFI): Commission must revisit its competition ruling against GSK »
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments